|
A study with Gemzar and LY293111 in patients with pancreatic cancer. Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on A study with Gemzar and LY293111 in patients with pancreatic cancer. conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. A study with Gemzar and LY293111 in patients with pancreatic cancer. Clinical research trials and A study with Gemzar and LY293111 in patients with pancreatic cancer. medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like A study with Gemzar and LY293111 in patients with pancreatic cancer.. A study with Gemzar and LY293111 in patients with pancreatic cancer. Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a A study with Gemzar and LY293111 in patients with pancreatic cancer. clinical trial. Subjects typically recieve the finest healthcare available for their A study with Gemzar and LY293111 in patients with pancreatic cancer. condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A study with Gemzar and LY293111 in patients with pancreatic cancer.  A study with Gemzar and LY293111 in patients with pancreatic cancer.
A study with Gemzar and LY293111 in patients with pancreatic cancer.
For Condition: Pancreatic Cancer
Status: Recruiting
Sponsor(s): Eli Lilly and Company ,
Synopsis: The purpose of this study is to determine the effectiveness and side effects of LY293111 given in combination with gemcitabine in patients with pancreatic cancer.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Adenocarcinoma of the pancreas - Tumor that can be measured by x-ray or scan - Adequate organ function Exclusion Criteria: - Inability to swallow capsules - Documented brain metastases - Previous treatment for this cancer
Total Enrollment:
Location and Contact Information:
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." *Recruiting*
Lakeland, Florida,
United States
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." *Recruiting*
Houston, Texas,
United States
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." *Recruiting*
Helsinki, ,
Finland
Recruiting
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." *Recruiting*
Birmingham, Alabama,
United States
Recruiting
Additional Information:
Study ID Numbers: 4840;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00055250
Other Pancreatic Cancer Studies:
1. LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
2. Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas
3. Vaccine Therapy with Tumor Specific Mutated P53 or Ras Peptides Alone or in Combination with Cellular Immunotherapy with Peptide Activated Lymphocytes (PAL Cells) Along with Subcutaneous IL-2
4. Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
5. Intraperitoneal and Intravenous Gemcitabine, Radiotherapy and Surgery for Advanced Cancer of the Pancreas
Related Studies:
Other Pancreatic Cancer Clinical Trials
Other Alabama Clinical Trials
Other Birmingham Clinical Trials
A study with Gemzar and LY293111 in patients with pancreatic cancer.
|
|
|
|
|
|
|
|
